 |
 |
 |
|
MONOTHERAPY WITH THE CAPSID ASSEMPLY MODULATOR, ALG-000184, RESULTS IN HIGH VIRAL SUPPRESSION RATES IN UNTREATED HBEAG+ AND HBEAG- SUBJECTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
|
|
|
Discovery & Preclinical Profile of ALG-000184
AASLD 2024 Nov 15-19 San Diego
Man-Fung Yuen1, Edward Gane2, Christian Schwabe3, Alina Jucov4, Alexei Haceatraian4, Min Wu5, Kha Le5, Jen Rito5, Maida Maderazo5, Lawrence M. Blatt5, Sushmita Chanda5, Tse-I Lin5, Matthew McClure5, Kosh Agarwal6







|
|
|
 |
 |
|
|